About Axcella

Our Purpose

We are a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous metabolic modulator (EMM) compositions. EMMs fundamentally impact and regulate metabolism, controlling many of the biological functions that are integral to health and disease. At Axcella, we are seeking to unlock the full potential of EMMs by combining a deep understanding of biological pathways with recent advances in systems biology and machine learning. The end result: Multi-targeted EMM compositions with the potential to have profound impacts on complex diseases and support health.

Our Values

ownership

Ownership

To be an Axcellan is to be an owner, acting for the benefit of the entire company. We are all rolling up our sleeves and working in unison to get the job done.

determination

Determination

We act with urgency to advance our product candidates. This requires relentless focus, prioritization and the willingness to make smart trade-off decisions by considering quality, speed and risk.

collaboration

Collaboration

We foster an inclusive culture, actively seeking diverse perspectives. We believe that the diverse expertise and experiences of Axcellans enriches our way of thinking and is essential to achieving our goals.

learning

Learning

We see change, ambiguity and complexity as a rich opportunity for learning. We encourage our employees to openly share their learnings throughout the organization, so we can actively incorporate these insights into our work.

Leadership

Board of Directors

gary

Gary Pisano, Ph.D.

Harry E. Figgie Professor of Business Administration, Harvard Business School

Learn more about our expertise

Patents

We are establishing a broad, global intellectual property portfolio

View

Publications

We are publishing innovative research and presenting at leading conferences.

View

Join Us

We value bright minds, collaborative approaches and energetic spirits.

View

Contact Us

Whether you are a potential employee, business partner or investor, we want to hear from you.

View

Scientific Advisors

Jeffrey Flier, M.D.

Distinguished Service Professor & Higginson Professor of Physiology and Medicine, Harvard Medical School

Christopher Newgard, Ph.D.

Director, Sarah W. Stedman Nutrition and Metabolism Center Director, Duke Molecular Physiology Institute

Michael Rosenblatt, M.D.

Chief Medical Officer, Flagship Pioneering

Nancy Thornberry

Chief Executive Officer, Kallyope

Jerry Vockley, M.D., Ph.D.

Cleveland Family Professor of Pediatric Research Professor of Human Genetics University of Pittsburgh